Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Christina Siesing"'
Autor:
Christina Siesing, Halfdan Sorbye, Anca Dragomir, Per Pfeiffer, Camilla Qvortrup, Fredrik Pontén, Karin Jirström, Bengt Glimelius, Jakob Eberhard
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182512 (2017)
High expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate, with prolonged survival in several malignant diseases and with the benefit of platinum-based chemotherapy in ovarian cancer. The aim of this study was to evaluate
Externí odkaz:
https://doaj.org/article/06c949eda58648e39cb16adef866f642
Autor:
Christina Siesing, Alexandra Petersson, Thora Ulfarsdottir, Subhayan Chattopadhyay, Björn Nodin, Jakob Eberhard, Jenny Brändstedt, Ingvar Syk, David Gisselsson, Karin Jirström
Publikováno v:
Modern Pathology. 35:979-988
In a non-negligible number of patients with metastatic colorectal cancer (mCRC), the peritoneum is the predominant site of dissemination. Cure can be achieved by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), but t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aabdfbfaab0421a1d4cf4a1802c81dde
https://doi.org/10.1038/s41379-022-01012-y
https://doi.org/10.1038/s41379-022-01012-y
Autor:
Jakob Eberhard, Christina Siesing, Hans Brunnström, Karin Jirström, Björn Nodin, Halla Vidarsdottir, Per Jönsson
Publikováno v:
Journal of Surgical Oncology. 123:1144-1156
Background The lungs are the second most common site of metastases in colorectal cancer (CRC). The aim of this study was to investigate prognostic factors, including RNA‐binding motif protein 3 (RBM3) expression, in patients with CRC treated with p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91938dacaea2952ad28372178445c1da
https://doi.org/10.1002/jso.26375
https://doi.org/10.1002/jso.26375
Autor:
Christina Siesing, Kristine Aasebø, Fredrik Pontén, Karin Jirström, Halfdan Sorbye, Emelie Karnevi, Björn Nodin, A. Petersson, Jakob Eberhard, Per Pfeiffer, C. Qvortrup, Anders Larsson, Bengt Glimelius
Publikováno v:
Annals of Oncology. 31:S446-S447
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98276ccb56bd9654952c03934ba83fae
https://doi.org/10.1016/j.annonc.2020.08.596
https://doi.org/10.1016/j.annonc.2020.08.596
Publikováno v:
Annals of Oncology. 30:v246
Background Obesity is a well-known risk factor for colorectal cancer (CRC), the relative risk being higher in men than in women, and for colon than for rectal cancer. Whether this risk differs by sidedness of colon cancer and sex, has however not yet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51be9fce79b97a76dde7a935bbaea073
https://doi.org/10.1093/annonc/mdz246.132
https://doi.org/10.1093/annonc/mdz246.132
Autor:
Christina Siesing, Karin Jirström, David Borg, Charlotta Hedner, Maria C. Svensson, Björn Nodin
Publikováno v:
Annals of Oncology. 29:viii220
Background: Neoadjuvant and/or adjuvant treatment has led to an improved survival in patients with resectable gastroesophageal adenocarcinoma (GEAC). Nevertheless, survival rates remain poor and, hence, there is a great need to identify novel treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6997fe3d4dbb855a9f05dddcfe89049
https://doi.org/10.1093/annonc/mdy282.039
https://doi.org/10.1093/annonc/mdy282.039
Autor:
Per Pfeiffer, Björn Nodin, Anca Dragomir, Jakob Eberhard, Bengt Glimelius, Fredrik Pontén, Christina Siesing, Camilla Qvortrup, Karin Jirström, Halfdan Sorbye
Publikováno v:
Siesing, C, Sorbye, H, Dragomir, A, Pfeiffer, P, Qvortrup, C, Ponten, F, Nodin, B, Glimelius, B, Eberhard, J & Jirstrom, K 2018, ' Prognostic significance of SATB1 expression in metastatic colorectal cancer: A Nordic prospective cohort study. ', Journal of Clinical Oncology, vol. 36, no. Suppl. 4, pp. 707 . https://doi.org/10.1200/JCO.2018.36.4_suppl.707
707 Background: Special AT-rich sequence binding protein 1 (SATB1) is a transcription factor involved in global gene regulation. SATB1 expression has been associated with poor prognosis in numerous cancer forms, including colorectal cancer (CRC). The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c23e1d011714d2e1f597d2e2ab87feb
https://doi.org/10.1200/jco.2018.36.4_suppl.707
https://doi.org/10.1200/jco.2018.36.4_suppl.707
Autor:
Bengt Glimelius, Halfdan Sorbye, Fredrik Pontén, Camilla Qvortrup, Jakob Eberhard, Anca Dragomir, Per Pfeiffer, Karin Jirström, Christina Siesing
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182512 (2017)
PLoS ONE
Siesing, C, Sorbye, H, Dragomir, A, Pfeiffer, P, Qvortrup, C, Pontén, F, Jirström, K, Glimelius, B & Eberhard, J 2017, ' High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer ', PLOS ONE, vol. 12, no. 8, e0182512 . https://doi.org/10.1371/journal.pone.0182512
PLoS ONE
Siesing, C, Sorbye, H, Dragomir, A, Pfeiffer, P, Qvortrup, C, Pontén, F, Jirström, K, Glimelius, B & Eberhard, J 2017, ' High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer ', PLOS ONE, vol. 12, no. 8, e0182512 . https://doi.org/10.1371/journal.pone.0182512
Background: High expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate, with prolonged survival in several malignant diseases and with the benefit of platinum-based chemotherapy in ovarian cancer. The aim of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de6bcba1fa821452bb61d1ab04468cd
https://doi.org/10.1371/journal.pone.0182512
https://doi.org/10.1371/journal.pone.0182512